Mega Genomics Limited (HKG:6667)
Hong Kong
· Delayed Price · Currency is HKD 7.20
-0.05 (-0.69%)
Mar 31, 2025, 3:45 PM HKT
Mega Genomics Revenue
Mega Genomics had revenue of 107.29M CNY in the half year ending June 30, 2024, with 9.91% growth. This brings the company's revenue in the last twelve months to 159.71M, up 8.66% year-over-year. In the year 2023, Mega Genomics had annual revenue of 151.30M with 3.82% growth.
Revenue (ttm)
159.71M CNY
Revenue Growth
+8.66%
P/S Ratio
9.41
Revenue / Employee
697.43K CNY
Employees
229
Market Cap
1.61B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 151.30M | 5.57M | 3.82% |
| Dec 31, 2022 | 145.73M | -91.46M | -38.56% |
| Dec 31, 2021 | 237.19M | 33.97M | 16.71% |
| Dec 31, 2020 | 203.22M | 79.52M | 64.28% |
| Dec 31, 2019 | 123.70M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| CSPC Pharmaceutical Group | 30.87B |